Pre-surgery rehab boosts recovery in limb sarcoma patients, early trial suggests
NCT ID NCT04515459
First seen Jun 26, 2026 ยท Last updated Jun 26, 2026
Summary
This study tests whether a personalized program of exercise, nutrition advice, and mental support before surgery can improve recovery and quality of life in people with bone or soft-tissue sarcoma of the arm or leg. About 53 participants will be followed for two years after surgery. The main goal is to see if more patients achieve good limb function 24 months after surgery.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- Active substance
- Surgical prehabilitation program (exercise, nutrition, and psychological support)
- What this could lead to
- If it works, this program could help people with limb sarcoma recover better and faster after surgery, with less disability and better quality of life.
- What could go wrong
- This is a small, early-phase study with only 53 people, so results may not apply to everyone. The program is extra work for patients and may not improve outcomes more than standard care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SARCOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Institut Universitaire du Cancer de Toulouse - Oncopole
RECRUITINGToulouse, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can engineered immune cells tackle childhood sarcoma?
- Can a Patient's own immune cells be engineered to fight a rare sarcoma?
- Can a Patient's own immune cells fight advanced sarcoma?
- Could a massive tissue bank unlock sarcoma's secrets?
- Can a new protein drug shield kids with cancer from dangerous infections?
- Can two drugs together fight Hard-to-Treat bone and Soft-Tissue cancers?